169 related articles for article (PubMed ID: 16819260)
1. [Retinoid therapy for autoimmune diseases].
Fukasawa H; Kagechika H; Shudo K
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Jun; 29(3):114-26. PubMed ID: 16819260
[TBL] [Abstract][Full Text] [Related]
2. Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid.
Tobita T; Takeshita A; Kitamura K; Ohnishi K; Yanagi M; Hiraoka A; Karasuno T; Takeuchi M; Miyawaki S; Ueda R; Naoe T; Ohno R
Blood; 1997 Aug; 90(3):967-73. PubMed ID: 9242525
[TBL] [Abstract][Full Text] [Related]
3. New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation.
Kitamura K; Kiyoi H; Yoshida H; Tobita T; Takeshita A; Ohno R; Naoe T
Cancer Chemother Pharmacol; 1997; 40 Suppl():S36-41. PubMed ID: 9272132
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulant effects of synthetic retinoids.
Koyama T; Shibakura M
Leuk Lymphoma; 1998 Sep; 31(1-2):71-80. PubMed ID: 9720716
[TBL] [Abstract][Full Text] [Related]
5. Tamibarotene: a candidate retinoid drug for Alzheimer's disease.
Fukasawa H; Nakagomi M; Yamagata N; Katsuki H; Kawahara K; Kitaoka K; Miki T; Shudo K
Biol Pharm Bull; 2012; 35(8):1206-12. PubMed ID: 22863914
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant effects of synthetic retinoids and activated vitamin D3.
Koyama T; Hirosawa S
Semin Thromb Hemost; 1998; 24(3):217-26. PubMed ID: 9701451
[TBL] [Abstract][Full Text] [Related]
7. Arginine of retinoic acid receptor beta which coordinates with the carboxyl group of retinoic acid functions independent of the amino acid residues responsible for retinoic acid receptor subtype ligand specificity.
Zhang ZP; Hutcheson JM; Poynton HC; Gabriel JL; Soprano KJ; Soprano DR
Arch Biochem Biophys; 2003 Jan; 409(2):375-84. PubMed ID: 12504905
[TBL] [Abstract][Full Text] [Related]
8. Tamibarotene.
Miwako I; Kagechika H
Drugs Today (Barc); 2007 Aug; 43(8):563-8. PubMed ID: 17925887
[TBL] [Abstract][Full Text] [Related]
9. Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide.
Sanford D; Lo-Coco F; Sanz MA; Di Bona E; Coutre S; Altman JK; Wetzler M; Allen SL; Ravandi F; Kantarjian H; Cortes JE
Br J Haematol; 2015 Nov; 171(4):471-7. PubMed ID: 26205361
[TBL] [Abstract][Full Text] [Related]
10. International Union of Pharmacology. LX. Retinoic acid receptors.
Germain P; Chambon P; Eichele G; Evans RM; Lazar MA; Leid M; De Lera AR; Lotan R; Mangelsdorf DJ; Gronemeyer H
Pharmacol Rev; 2006 Dec; 58(4):712-25. PubMed ID: 17132850
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid receptor stimulation ameliorates experimental autoimmune optic neuritis.
Keino H; Watanabe T; Sato Y; Shudo K; Kitaoka Y; Harada T; Okada AA
Clin Exp Ophthalmol; 2015 Aug; 43(6):558-67. PubMed ID: 24612001
[TBL] [Abstract][Full Text] [Related]
12. Relapsed acute promyelocytic leukemia previously treated with all-trans retinoic acid: clinical experience with a new synthetic retinoid, Am-80.
Takeuchi M; Yano T; Omoto E; Takahashi K; Kibata M; Shudo K; Harada M; Ueda R; Ohno R
Leuk Lymphoma; 1998 Nov; 31(5-6):441-51. PubMed ID: 9922035
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
Peng X; Yun D; Christov K
Int J Oncol; 2004 Oct; 25(4):961-71. PubMed ID: 15375546
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of relapse of acute promyelocytic leukemia with a new synthetic retinoid, Am80.
Takeshita A; Shibata Y; Shinjo K; Yanagi M; Tobita T; Ohnishi K; Miyawaki S; Shudo K; Ohno R
Ann Intern Med; 1996 May; 124(10):893-6. PubMed ID: 8610919
[No Abstract] [Full Text] [Related]
15. [Clinical experience with a new synthetic retinoid, tamibarotene (Am-80) for relapsed or refractory acute promyelocytic leukemia].
Takeuchi M
Gan To Kagaku Ryoho; 2006 Mar; 33(3):397-401. PubMed ID: 16531727
[TBL] [Abstract][Full Text] [Related]
16. [State-of-the-art treatment of acute promyelocytic leukemia].
Kiguchi T
Rinsho Ketsueki; 2018; 59(10):2007-2018. PubMed ID: 30305503
[TBL] [Abstract][Full Text] [Related]
17. Re-induction of complete remission with a new synthetic retinoid, Am-80, for relapse of acute promyelocytic leukaemia previously treated with all-trans retinoic acid.
Takeuchi M; Yano T; Omoto E; Takahashi K; Kibata M; Shudo K; Ueda R; Ohno R; Harada M
Br J Haematol; 1997 Apr; 97(1):137-40. PubMed ID: 9136955
[TBL] [Abstract][Full Text] [Related]
18. Retinoic Acid and Its Derivatives in Skin.
Szymański Ł; Skopek R; Palusińska M; Schenk T; Stengel S; Lewicki S; Kraj L; Kamiński P; Zelent A
Cells; 2020 Dec; 9(12):. PubMed ID: 33322246
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated via retinoic acid receptor alpha.
Szondy Z; Reichert U; Bernardon JM; Michel S; Tóth R; Karászi E; Fésüs L
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):767-74. PubMed ID: 9560303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
